M. HANGÜL Et Al. , "Propranolol treatment for chylothorax due to diffuse lymphangiomatosis," PEDIATRIC BLOOD & CANCER , vol.66, no.5, 2019
HANGÜL, M. Et Al. 2019. Propranolol treatment for chylothorax due to diffuse lymphangiomatosis. PEDIATRIC BLOOD & CANCER , vol.66, no.5 .
HANGÜL, M., KÖSE, M., ÖZCAN, A., & ÜNAL, E., (2019). Propranolol treatment for chylothorax due to diffuse lymphangiomatosis. PEDIATRIC BLOOD & CANCER , vol.66, no.5.
HANGÜL, MELİH Et Al. "Propranolol treatment for chylothorax due to diffuse lymphangiomatosis," PEDIATRIC BLOOD & CANCER , vol.66, no.5, 2019
HANGÜL, MELİH Et Al. "Propranolol treatment for chylothorax due to diffuse lymphangiomatosis." PEDIATRIC BLOOD & CANCER , vol.66, no.5, 2019
HANGÜL, M. Et Al. (2019) . "Propranolol treatment for chylothorax due to diffuse lymphangiomatosis." PEDIATRIC BLOOD & CANCER , vol.66, no.5.
@article{article, author={MELİH HANGÜL Et Al. }, title={Propranolol treatment for chylothorax due to diffuse lymphangiomatosis}, journal={PEDIATRIC BLOOD & CANCER}, year=2019}